Correction: ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells

Lignende værker

• ErbB Inhibitory Protein [EBIP]: A Modified Ectodomain of EGFR Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells
  af: Nautiyal, Jyoti, et al.
  Udgivet: (2010)
• Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains
  af: O’Rourke, Donald M., et al.
  Udgivet: (1997)
• The Inhibitory Effect of ErbB2 on Epidermal Growth Factor-induced Formation of Clathrin-coated Pits Correlates with Retention of Epidermal Growth Factor Receptor-ErbB2 Oligomeric Complexes at the Plasma Membrane
  af: Haslekås, Camilla, et al.
  Udgivet: (2005)
• ErbB2 Immune Response in Breast Cancer Patients with Soluble Receptor Ectodomain
  af: Visco, Vincenzo, et al.
  Udgivet: (2000)
• Desensitization by Different Strategies of Epidermal Growth Factor Receptor and ErbB4
  af: Hideyuki Yamamoto, et al.
  Udgivet: (2014-01-01)